BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

Dow Jones 30 Stocks SEC Filings β€” February 17, 2026

USA Dow Jones 30

37 high priority51 medium priority88 total filings analysed

Executive Summary

On February 18, 2026, 88 8-K filings flooded the SEC docket in the USA Dow Jones 30 intelligence stream, dominated by ~45 earnings-related disclosures (Item 2.02, avg materiality 6.9/10) signaling the onset of Q4 2025 earnings season, though no YoY/QoQ revenue, earnings, or margin trends disclosed across any. ~21 filings (24%) detailed entry into material definitive agreements (Item 1.01, avg materiality 8/10), pointing to a surge in M&A, partnerships, or financing deals amid neutral sentiment portfolio-wide due to absent quantitative enriched data like financial ratios, operational metrics, or guidance. Leadership churn evident in 15 Item 5.02 filings (avg materiality 4.5/10), with no insider trading patterns, capital allocation (dividends/buybacks), or forward-looking targets provided. Financial obligations noted in 9 filings (Item 2.03), raising dilution/leverage risks via Item 3.02 equity sales in 4 cases. No period-over-period comparisons available, but cross-filing patterns show outliers like urban-gro (3 filings) and high-materiality deals (e.g., LIXTE BIOTECHNOLOGY 9/10) as catalysts. Implications: Investors should prioritize exhibit reviews for hidden trends; M&A wave bullish for growth but risky without terms.

Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from February 16, 2026.

Investment Signals(12)

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Earnings Season Launch
    β—†

    ~45/88 filings (51%) with Item 2.02 (e.g., CVR Energy, Analog Devices, Booking), no disclosed YoY trends but high avg materiality 7/10; implies broad blue-chip check-in, action: parse exhibits for revenue/margin deltas

  • M&A/Partnership Surge
    β—†

    21/88 (24%) Item 1.01 (e.g., urban-gro x3, Gladstone), clustered in biotech/energy/tech; bullish deal flow sans valuations/terms, avg materiality 8/10, watch for synergies

  • Leadership Churn Pattern
    β—†

    15/88 (17%) Item 5.02 (e.g., Global Payments, Health Catalyst), low materiality avg 4/10 but cross-sector (fintech/healthcare); potential instability signal vs continuity

  • Financing/Dilution Wave
    β—†

    9 Item 2.03 + 4 Item 3.02 (e.g., Energy Vault, Avalon), medium risk avg; capital access theme but leverage concerns, implications for small-cap balance sheets

  • Neutral Sentiment Overhang
    β—†

    86/88 neutral (2 mixed), no guidance/insider data; 40%+ multi-item filings (earnings+Reg FD), delays actionable trends to earnings calls

  • DJ30-Relevant Clusters
    β—†

    Filings from semis (Marvell/Analog), fintech (Global Payments), travel (Booking/T&L), utilities (Edison); no metrics but portfolio watch for sector rotation

Watch List(8)

Filing Analyses(88)
urban-gro, Inc.8-Kneutralmateriality 8/10

18-02-2026

urban-gro, Inc. filed a Form 8-K on 2026-02-18 reporting entry into a Material Definitive Agreement under Item 1.01, Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, counterparties, financial terms, or impacts provided. No revenue, earnings, balance sheet effects, guidance changes, or other quantitative metrics are disclosed.

  • Β·File size: 1 MB
  • Β·Accession Number: 0001213900-26-017587
  • Β·Sector: NOT_DISCLOSED
NewAmsterdam Pharma Co N.V.8-Kneutralmateriality 5/10

18-02-2026

NewAmsterdam Pharma Co N.V. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-056020), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative financial metrics are available for analysis.

Cannabist Co Holdings Inc.8-Kneutralmateriality 9/10

18-02-2026

Cannabist Co Holdings Inc. filed a Form 8-K on 2026-02-18 (AccNo: 0001776738-26-000004, size 131 KB) reporting under Item 1.01 its entry into a material definitive agreement. No details on the agreement's parties, terms, value, strategic rationale, or financial implications are disclosed. No quantitative metrics, positive or negative performance indicators, or forward-looking guidance are provided.

  • Β·AccNo: 0001776738-26-000004
  • Β·Event date aligns with filing date: 2026-02-18
GLADSTONE INVESTMENT CORPORATION\DE8-Kneutralmateriality 8/10

18-02-2026

Gladstone Investment Corporation filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 reporting the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

CVR ENERGY INC8-Kneutralmateriality 8/10

18-02-2026

CVR Energy Inc filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, or other quantitative metrics are provided in the filing summary. No positive or negative performance details, guidance, or comparisons are mentioned.

Marvell Technology, Inc.8-Kneutralmateriality 4/10

18-02-2026

Marvell Technology, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-055923), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, period-over-period changes, positive or negative performance indicators, or other material facts are available.

urban-gro, Inc.8-K/Amixedmateriality 8/10

18-02-2026

urban-gro, Inc. filed an 8-K on 2026-02-18 reporting under Item 1.01 its entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, indicating potential strategic or financing activity. However, no details on transaction size, terms, parties, financial impact, or dilution effects are disclosed. This multi-item filing is informational without quantified metrics.

  • Β·AccNo: 0001213900-26-017595
  • Β·File size: 203 KB
urban-gro, Inc.8-K/Aneutralmateriality 7/10

18-02-2026

urban-gro, Inc. filed an 8-K on 2026-02-18 (AccNo: 0001213900-26-017516) disclosing under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No details on the agreement's parties, terms, value, financial impacts, or strategic context are disclosed.

Travel & Leisure Co.8-Kneutralmateriality 7/10

18-02-2026

Travel & Leisure Co. filed an 8-K on February 18, 2026 (AccNo: 0001361658-26-000005), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific quantitative metrics, period-over-period comparisons, or guidance details. No positive or negative performance indicators are mentioned.

Cinemark Holdings, Inc.8-Kneutralmateriality 6/10

18-02-2026

Cinemark Holdings, Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. All transaction values, percentages, and operational data are NOT_DISCLOSED.

Energy Vault Holdings, Inc.8-Kneutralmateriality 8/10

18-02-2026

Energy Vault Holdings, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001104659-26-016759), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, financial impacts, or strategic context provided in the summary. No positive or negative metrics, period-over-period changes, or guidance revisions are disclosed.

GLOBAL PAYMENTS INC8-Kneutralmateriality 5/10

18-02-2026

GLOBAL PAYMENTS INC filed an 8-K on 2026-02-18 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including position, appointment or resignation, reasons, financial metrics, or performance comparisons are NOT_DISCLOSED.

Bausch & Lomb Corp8-Kneutralmateriality 5/10

18-02-2026

Bausch & Lomb Corp filed a Form 8-K on 2026-02-18 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics were mentioned in the filing details provided. This appears to be a standard mandatory earnings-related disclosure without quantified performance data available.

ANALOG DEVICES INC8-Kneutralmateriality 8/10

18-02-2026

Analog Devices Inc filed an 8-K on February 18, 2026 (AccNo: 0000006281-26-000015), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or quantitative metrics are detailed in the provided information. No positive or negative performance indicators, period-over-period comparisons, or transaction values were mentioned.

ONESPAWORLD HOLDINGS Ltd8-Kneutralmateriality 7/10

18-02-2026

ONESPAWORLD HOLDINGS Ltd filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056024), reporting under Item 2.02 for Results of Operations and Financial Condition, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard voluntary earnings-related disclosure without detailed performance data.

Verisk Analytics, Inc.8-Kneutralmateriality 7/10

18-02-2026

Verisk Analytics, Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the filing summary provided.

Vita Coco Company, Inc.8-Kneutralmateriality 5/10

18-02-2026

Vita Coco Company, Inc. filed a Form 8-K on February 18, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be an informational earnings-related disclosure without detailed performance data.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.8-Kneutralmateriality 7/10

18-02-2026

Charles River Laboratories International, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001100682-26-000020), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard voluntary earnings disclosure filing, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. No positive, negative, or flat performance indicators are available.

Wingstop Inc.8-Kneutralmateriality 7/10

18-02-2026

Wingstop Inc. filed an 8-K on February 18, 2026, disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related multi-item filing with no directional performance data available.

TripAdvisor, Inc.8-Kneutralmateriality 3/10

18-02-2026

TripAdvisor, Inc. filed a Form 8-K on February 18, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing metadata. This appears to be an informational filing without quantified impacts.

CREATIVE REALITIES, INC.8-Kneutralmateriality 8/10

18-02-2026

CREATIVE REALITIES, INC. filed an 8-K on February 18, 2026 (AccNo: 0001437749-26-004453), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or quantitative metrics disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

BREAD FINANCIAL HOLDINGS, INC.8-Kneutralmateriality 7/10

18-02-2026

Bread Financial Holdings, Inc. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 1.02 Termination of a Material Definitive Agreement. No financial details, transaction values, or impacts are disclosed. No quantitative metrics or period-over-period comparisons are provided.

Madison Square Garden Sports Corp.8-Kneutralmateriality 4/10

18-02-2026

Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.

Innventure, Inc.8-Kneutralmateriality 3/10

18-02-2026

Innventure, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0002001557-26-000024, Size: 176 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosed information, transaction values, financial metrics, or exhibits provided. No quantitative data, performance metrics, positives, negatives, or comparisons are mentioned.

Theriva Biologics, Inc.8-Kneutralmateriality 8/10

18-02-2026

Theriva Biologics, Inc. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. This is a multi-item mandatory and voluntary filing, but no details on the agreement's nature, parties, value, or financial impacts are provided in the available information. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

  • Β·AccNo: 0001104659-26-016792
  • Β·Filing size: 677 KB
Avalon GloboCare Corp.8-Kneutralmateriality 5/10

18-02-2026

Avalon GloboCare Corp. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017682, Size: 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing involves a voluntary disclosure of material nonpublic information with attached exhibits. No financial metrics, transactions, or specific details are provided in the filing summary.

  • Β·File size: 222 KB
  • Β·Accession Number: 0001213900-26-017682
SONIC AUTOMOTIVE INC8-Kneutralmateriality 5/10

18-02-2026

Sonic Automotive Inc filed an 8-K on February 18, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the filing details provided. This is a multi-item filing focused on earnings release with no directional financial data available.

IMAC Holdings, Inc.8-Kneutralmateriality 7/10

18-02-2026

IMAC Holdings, Inc. filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

PROG Holdings, Inc.8-Kneutralmateriality 8/10

18-02-2026

PROG Holdings, Inc. filed a Form 8-K on February 18, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are detailed in the provided filing information. This is a standard multi-item earnings-related disclosure with no indicated positive or negative performance variations.

LIXTE BIOTECHNOLOGY HOLDINGS, INC.8-Kneutralmateriality 9/10

18-02-2026

LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed a Form 8-K on 2026-02-18 disclosing entry into a Material Definitive Agreement (Item 1.01), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement's nature, parties, terms, financial impacts, or quantitative metrics provided. No performance metrics, positive or negative changes, or period-over-period comparisons were mentioned.

La Rosa Holdings Corp.8-Kneutralmateriality 8/10

18-02-2026

La Rosa Holdings Corp. filed a Form 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed. This multi-item filing signals material developments but lacks quantitative context for assessment.

QT IMAGING HOLDINGS, INC.8-Kneutralmateriality 5/10

18-02-2026

QT Imaging Holdings, Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings announcements.

Liberty Global Ltd.8-Kneutralmateriality 7/10

18-02-2026

Liberty Global Ltd. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.

Health Catalyst, Inc.8-Kneutralmateriality 5/10

18-02-2026

Health Catalyst, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or any quantitative metrics are provided. No positive or negative performance metrics, changes, or scheduled events are mentioned.

PROGRESSIVE CORP/OH/8-Kneutralmateriality 4/10

18-02-2026

Progressive Corp/OH/ filed an 8-K on February 18, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material non-public information via press release or update, with attached exhibits. No specific financial metrics, transactions, events, or performance data (positive, negative, or flat) are disclosed in the filing summary.

Eva Live Inc8-Kneutralmateriality 2/10

18-02-2026

Eva Live Inc filed a Form 8-K on February 18, 2026 (AccNo: 0001493152-26-007297, Size: 236 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative financial metrics, transactions, or performance data mentioned.

M Evo Global Acquisition Corp II8-Kneutralmateriality 5/10

18-02-2026

M Evo Global Acquisition Corp II filed an 8-K on 2026-02-18 disclosing other events under Item 8.01 in the context of a merger/acquisition, with Item 9.01 providing financial statements and exhibits. No specific deal structure, parties, financial metrics, or impacts are disclosed. No positive or negative metrics are present.

Heritage Distilling Holding Company, Inc.8-Kneutralmateriality 3/10

18-02-2026

Heritage Distilling Holding Company, Inc. filed a Form 8-K on February 18, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, alongside Regulation FD Disclosure under Item 7.01. Item 9.01 includes financial statements and exhibits. No specific details, quantitative impacts, positive or negative metrics, or dollar values are disclosed in the filing summary.

WASHINGTON TRUST BANCORP INC8-Kneutralmateriality 3/10

18-02-2026

Washington Trust Bancorp Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed in the provided information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.

  • Β·AccNo: 0000737468-26-000031
  • Β·File Size: 165 KB
  • Β·Sector: not specified
EDISON INTERNATIONAL8-Kneutralmateriality 7/10

18-02-2026

Edison International filed an 8-K on February 18, 2026 (AccNo: 0000827052-26-000010), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, or other quantitative metrics are mentioned in the provided filing information.

EBAY INC8-Kneutralmateriality 7/10

18-02-2026

eBay Inc filed an 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no detailed quantitative data available.

Mativ Holdings, Inc.8-Kneutralmateriality 8/10

18-02-2026

Mativ Holdings, Inc. filed an 8-K on February 18, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a standard earnings-related disclosure with no specific revenue, earnings, margins, guidance, or period-over-period metrics provided in the filing summary. No positive or negative financial changes are detailed.

FB Bancorp, Inc. /MD/8-Kneutralmateriality 5/10

18-02-2026

FB Bancorp, Inc. (/MD/) filed a Form 8-K on February 18, 2026 (AccNo: 0001193125-26-057030), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are provided in the filing details.

Nextdoor Holdings, Inc.8-Kneutralmateriality 7/10

18-02-2026

Nextdoor Holdings, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001846069-26-000022), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This multi-item filing discloses financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned. No positive or negative performance indicators, period-over-period comparisons, or operational details are provided.

CARVANA CO.8-Kneutralmateriality 8/10

18-02-2026

Carvana Co. filed a Form 8-K on February 18, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure without quantified performance data.

Grand Canyon Education, Inc.8-Kneutralmateriality 7/10

18-02-2026

Grand Canyon Education, Inc. filed a Form 8-K on February 18, 2026, under Items 2.02 and 9.01, disclosing results of operations and financial condition along with financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. All quantitative financial metrics remain NOT_DISCLOSED.

AVIS BUDGET GROUP, INC.8-Kneutralmateriality 7/10

18-02-2026

Avis Budget Group, Inc. filed an 8-K on February 18, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings announcement filing.

FLYEXCLUSIVE INC.8-Kneutralmateriality 8/10

18-02-2026

flyExclusive Inc. filed an 8-K on February 18, 2026, under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

Booking Holdings Inc.8-Kneutralmateriality 7/10

18-02-2026

Booking Holdings Inc. filed a Form 8-K on February 18, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, transaction values, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financial statements, but detailed quantitative data is NOT_DISCLOSED.

TruGolf Holdings, Inc.8-Kneutralmateriality 4/10

18-02-2026

TruGolf Holdings, Inc. filed a Form 8-K on February 18, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 discloses financial statements and exhibits, likely including vote tabulations or related documents. No specific vote outcomes, quantitative metrics, or financial details are provided in the filing summary.

HCM IV Acquisition Corp.8-Kneutralmateriality 8/10

18-02-2026

HCM IV Acquisition Corp. filed an 8-K on 2026-02-18 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. The filing relates to a merger/acquisition event but provides no specific details on parties, valuation, terms, or financial metrics. No quantitative data or performance comparisons are disclosed.

Remitly Global, Inc.8-Kneutralmateriality 3/10

18-02-2026

Remitly Global, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.

Brookdale Senior Living Inc.8-Kneutralmateriality 8/10

18-02-2026

Brookdale Senior Living Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, margins, or other quantitative metrics are provided in the available information. No positive or negative performance indicators, guidance changes, or comparisons are detailed.

YUNHONG GREEN CTI LTD.8-Kneutralmateriality 5/10

18-02-2026

YUNHONG GREEN CTI LTD. filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

RE/MAX Holdings, Inc.8-Kneutralmateriality 4/10

18-02-2026

RE/MAX Holdings, Inc. filed an 8-K on February 18, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, appointment/resignation, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, performance comparisons, or governance impacts are disclosed.

Neptune Insurance Holdings Inc.8-Kneutralmateriality 3/10

18-02-2026

Neptune Insurance Holdings Inc. filed a Form 8-K on 2026-02-18 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or period-over-period comparisons were disclosed in the provided filing information. This represents a standard voluntary earnings announcement without detailed quantitative metrics.

Permianville Royalty Trust8-Kneutralmateriality 4/10

18-02-2026

Permianville Royalty Trust filed an 8-K on February 18, 2026 (AccNo: 0001104659-26-017065), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, distributions, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing summary. This is a multi-item filing focused on financial results disclosure for the royalty trust.

MOLSON COORS BEVERAGE CO8-Kneutralmateriality 5/10

18-02-2026

Molson Coors Beverage Co filed an 8-K on 2026-02-18 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results. This multi-item filing provides an executive summary of financial performance but no specific revenue, earnings, or other metrics are explicitly stated in the provided filing description. No positive or negative performance indicators, guidance, or scheduled events are detailed.

Coca-Cola Consolidated, Inc.8-Kneutralmateriality 8/10

18-02-2026

Coca-Cola Consolidated, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001628280-26-009048), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

Invitation Homes Inc.8-Kneutralmateriality 7/10

18-02-2026

Invitation Homes Inc. filed an 8-K on February 18, 2026 (AccNo: 0001687229-26-000013, Size: 9 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings disclosure with attached exhibits.

Greenlane Holdings, Inc.8-Kneutralmateriality 6/10

18-02-2026

Greenlane Holdings, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, or timing are disclosed.

Bausch Health Companies Inc.8-Kneutralmateriality 7/10

18-02-2026

Bausch Health Companies Inc. filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached financial statements.

CITIZENS FINANCIAL SERVICES INC8-Kneutralmateriality 3/10

18-02-2026

CITIZENS FINANCIAL SERVICES INC filed an 8-K on February 18, 2026, specifically under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), with Accession Number 0000739421-26-000013 and file size of 164 KB. No details on the nature of the other events or contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are provided in the filing description.

Remitly Global, Inc.8-Kneutralmateriality 9/10

18-02-2026

Remitly Global, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001628280-26-009031, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

Clearwater Analytics Holdings, Inc.8-Kneutralmateriality 8/10

18-02-2026

Clearwater Analytics Holdings, Inc. filed a Form 8-K on February 18, 2026 (AccNo: 0001866368-26-000009), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue figures, earnings, period-over-period comparisons, guidance, or other quantitative performance data are disclosed in the provided filing information. This appears to be an earnings-related disclosure, but detailed results remain NOT_DISCLOSED.

CVR PARTNERS, LP8-Kneutralmateriality 5/10

18-02-2026

CVR Partners, LP filed an 8-K on February 18, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with no quantified positive or negative performance indicators available.

  • Β·Filing Accession Number: 0001425292-26-000010
  • Β·File size: 428 KB
  • Β·Sector: NOT_DISCLOSED
California BanCorp \ CA8-Kneutralmateriality 4/10

18-02-2026

California BanCorp (CA) filed an 8-K on 2026-02-18 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons, financial metrics, or other quantitative details are disclosed.

Seven Hills Realty Trust8-Kneutralmateriality 7/10

18-02-2026

Seven Hills Realty Trust filed a Form 8-K on February 18, 2026 (AccNo: 0001452477-26-000009), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance variances.

Trulieve Cannabis Corp.8-Kneutralmateriality 4/10

18-02-2026

Trulieve Cannabis Corp. filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This is a routine SEC disclosure for leadership changes with no additional context provided.

CervoMed Inc.8-Kneutralmateriality 4/10

18-02-2026

CervoMed Inc. filed an 8-K on February 18, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with Accession Number 0001437749-26-004555 and file size of 198 KB. No specific events, financial metrics, transactions, positive or negative changes, or quantitative data are disclosed in the provided filing summary.

Warner Bros. Discovery, Inc.8-Kneutralmateriality 8/10

18-02-2026

Warner Bros. Discovery, Inc. filed an 8-K on February 18, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, dollar values, positive or negative impacts, or performance comparisons are disclosed.

HERBALIFE LTD.8-Kneutralmateriality 7/10

18-02-2026

Herbalife Ltd. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017966), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period changes, or segment details are mentioned.

Spring Valley Acquisition Corp. IV8-Kneutralmateriality 6/10

18-02-2026

Spring Valley Acquisition Corp. IV filed an 8-K on 2026-02-18 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific deal structure, parties involved beyond the filer, valuation, financial metrics, synergies, or regulatory details are disclosed in the provided filing information. This informational filing lacks quantitative data or directional performance indicators.

Reservoir Media, Inc.8-Kneutralmateriality 3/10

18-02-2026

Reservoir Media, Inc. filed an 8-K on February 18, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing metadata. The filing size is 6 MB, indicating potential exhibits such as presentations or statements.

CF Industries Holdings, Inc.8-Kneutralmateriality 6/10

18-02-2026

CF Industries Holdings, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001324404-26-000003), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a voluntary disclosure of financial results with attached exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information.

LiveRamp Holdings, Inc.8-Kneutralmateriality 3/10

18-02-2026

LiveRamp Holdings, Inc. filed an 8-K on 2026-02-18 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative terms are disclosed in the provided filing information. This is a routine governance disclosure with no additional financial or operational metrics mentioned.

M3-Brigade Acquisition V Corp.8-Kneutralmateriality 9/10

18-02-2026

M3-Brigade Acquisition V Corp. filed an 8-K on February 18, 2026, announcing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing includes financial statements and exhibits under Item 9.01. No specific transaction parties, deal terms, valuations, or financial metrics are disclosed.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.8-Kneutralmateriality 4/10

18-02-2026

Charles River Laboratories International, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officers, reasons for change, or quantitative impacts are disclosed.

CF Industries Holdings, Inc.8-Kneutralmateriality 5/10

18-02-2026

CF Industries Holdings, Inc. filed an 8-K on February 18, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed quantitative data available.

MVB FINANCIAL CORP8-Kneutralmateriality 4/10

18-02-2026

MVB Financial Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any financial metrics are disclosed. The filing appears routine with no quantified positive or negative impacts mentioned.

LanzaTech Global, Inc.8-Kneutralmateriality 8/10

18-02-2026

LanzaTech Global, Inc. filed an 8-K on 2026-02-18 (AccNo: 0001628280-26-009171, Size: 199 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement. No details on the agreement's nature, parties, dollar value, financial impacts, or strategic context were provided. This appears to be a single-item mandatory filing with sector not specified.

Pearl Diver Credit Co Inc.8-Kneutralmateriality 4/10

18-02-2026

Pearl Diver Credit Co Inc. filed an 8-K on February 18, 2026, reporting under Item 8.01 Other Events. No specific details on the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. Sector not specified.

ARKO Corp.8-Kneutralmateriality 8/10

18-02-2026

ARKO Corp. filed an 8-K on 2026-02-18 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing, but specific details on the agreement, transaction terms, financial impacts, or dollar values are NOT_DISCLOSED. No quantitative metrics, guidance changes, or scheduled events were provided.

ARKO Petroleum Corp.8-Kneutralmateriality 7/10

18-02-2026

ARKO Petroleum Corp. filed an 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative metrics, dollar values, period-over-period changes, or specific transaction details are provided.

Avalon GloboCare Corp.8-Kmixedmateriality 8/10

18-02-2026

Avalon GloboCare Corp. filed an 8-K on February 18, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 listing Financial Statements and Exhibits. While the material definitive agreement may indicate strategic developments, the financial obligation and unregistered equity sales could imply increased leverage or shareholder dilution. No specific transaction details, dollar values, terms, or financial metrics are disclosed.

SAFE & GREEN HOLDINGS CORP.8-Kneutralmateriality 8/10

18-02-2026

SAFE & GREEN HOLDINGS CORP. filed a Form 8-K on February 18, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, personnel names, dollar values, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary.

Liberty Global Ltd.8-Kneutralmateriality 2/10

18-02-2026

Liberty Global Ltd. filed a Form 8-K on February 18, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or impacts are mentioned.

JFB Construction Holdings8-Kneutralmateriality 8/10

18-02-2026

JFB Construction Holdings filed a multi-item Form 8-K on February 18, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, transaction values, financial impacts, personnel names, or quantitative metrics are disclosed in the provided filing summary. This mandatory disclosure signals potentially significant developments but lacks substance for directional assessment.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 88 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
Dow Jones 30 Stocks SEC Filings β€” February 17, 2026 | Gunpowder Blog